Q32 Bio
QTTB
QTTB
79 hedge funds and large institutions have $27.1M invested in Q32 Bio in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
29% less capital invested
Capital invested by funds: $38.4M → $27.1M (-$11.3M)
46% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 24
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
79
Holding in Top 10
–
Calls
$96K
Puts
$16K
Top Buyers
| 1 | +$110K | |
| 2 | +$50.4K | |
| 3 | +$31.5K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$30.8K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$19.5K |
Top Sellers
| 1 | -$1.12M | |
| 2 | -$413K | |
| 3 | -$346K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$328K |
| 5 |
Millennium Management
New York
|
-$276K |